U.S. Physical Therapy, Inc. (USPH)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at U.S. Physical Therapy, Inc..
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 8 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 79.10 $ — 59% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
3 of 10 Weak growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 12.2% failed
- More than 10% revenue growth is expected for the coming year 6.8% failed
- Share count grows by less than 3% a year 5.3% failed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 24.1% failed
- Gross margin at 40% or higher and without meaningful erosion 20.2% failed
- Goodwill from acquisitions does not grow faster than revenue 57.5% passed
- Net debt below twice EBITDA 3.6 x EBITDA failed
- Operating cash flow covers the profits of the last three years 176 m passed
- Return on capital at 15% or higher, or up versus two years ago 7.6% passed
- Insiders hold at least 10% or are net buyers 2.5% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Analysts & Price Target
The price target sits 18.4% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 7
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 2.93 | 2.75 – 3.17 | 840 | 11.3% | 6 |
| 12/31/2027 | 3.42 | 3.20 – 3.81 | 898 | 16.8% | 6 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 0.85 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.49 | – | 180 | 16.60 | 4.10 | 19 | 17 |
| 2025: Q1 | 0.65 | 48.70 | 153 | -2.00 | 6.50 | -5 | -7 |
| 2025: Q2 | 0.58 | 27.00 | 164 | -1.80 | 5.40 | 35 | 32 |
| 2025: Q3 | 0.48 | 29.90 | 164 | -2.40 | 4.40 | 20 | 16 |
| 2025: Q4 | -0.70 | -240.80 | 203 | 12.30 | -5.20 | 25 | 21 |
| 2026: Q1 | -0.29 | -143.70 | 198 | 30.00 | -2.20 | 4 | -1 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 357 | 50 | 21 | 1.64 | 51 | 188 | 351 |
| 2017 | 414 | 55 | 22 | 1.77 | 57 | 205 | 419 |
| 2018 | 454 | 60 | 10 | 0.80 | 73 | 216 | 443 |
| 2019 | 482 | 67 | 28 | 2.21 | 62 | 240 | 561 |
| 2020 | 423 | 52 | 31 | 2.38 | 100 | 276 | 594 |
| 2021 | 495 | 71 | 28 | 2.16 | 76 | 296 | 749 |
| 2022 | 553 | 57 | 28 | 2.18 | 59 | 316 | 858 |
| 2023 | 605 | 52 | 15 | 1.03 | 82 | 476 | 997 |
| 2024 | 671 | 63 | 26 | 1.76 | 75 | 489 | 1,167 |
| 2025 | 781 | 80 | 15 | 0.99 | 75 | 476 | 1,204 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
| CEO Insider Trades (12 Mo.) | selling own stock |
|---|---|
| Employees | 4,653 |
| Headquarters | Houston, TX |
| Address | 1300 West Sam Houston Parkway South, 77042 Houston, United States |
| Phone | 713 297 7000 |
| Website | usph.com |
| IPO Date | 28. May 1992 |
| ISIN | US90337L1089 |
| Stock Split | 3:2 on 06/29/2001 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Christopher J. Reading | CEO & Chairman | 1964 |
| Eric Joseph Williams | President & COO | 1966 |
| Richard S. Binstein | Executive VP, General Counsel & Secretary | 1961 |
| Graham D. Reeve M.B.A., P.T. | Chief Operating Officer - West | 1964 |
| Michael G. Mayrsohn | CEO of Metro & Director | 1987 |
| Jason T. Curtis | Interim CFO and Senior VP of Finance & Accounting | 1976 |
| Chadd Pence | Senior Vice President of Information Systems | – |
| Jayne Fleck Pool ATC, PT, SCS | Senior VP & Chief Compliance Officer | – |
| Jason Anderson | Vice President of Human Resources | – |
| Matthew J. Condon | Senior Vice President of Strategic Initiatives & Partnerships | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.